Canterbury DHB


High Dose Melphalan Conditioning

Calculation of Drug Dosages

In the seven schedules, drug dosage is related either to the patient’s actual body weight or by calculating the Body Surface area (BSA). Any dose reduction due to renal dysfunction or obesity is done by the Haematology Pharmacist in conjunction with the Transplant Consultant. See also Cytotoxic Drugs in the Drug Usage section.




Melphalan 200 mg/m2


Bone marrow/PBSC return. Ensure the stem cell infusion is given at least 24 hours post melphalan.

For more details, refer to:

  • Administration details for Melphalan.
  • Patient-specific schedule for Melphalan.
  • Chemo chart for Melphalan.
  • IV fluid chart for Melphalan.

About this Canterbury DHB document (10208):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

December 2016

Next Review:

December 2018


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 10208